Nice find. The benefit assessment and decision was already complete (hence their granting of HE). Price negotiations take at most 6 months, but can be hashed out sooner (also shown in slide 17). The Company also reiterated this point when they stated price negotiations would be worked out "over the coming months." So it would seem no later than August.
Slide 16: Abbreviated assessment for orphan drugs. Slide 23: Orphan drugs are exempted from benefit assessment.
Do you believe that DCVax-L might be able to go through the reimbursement negotiation process a bit faster than "average" based on special situation, ie: Hospital Exemption & see page 20: large additional benefit with high quality of evidence?